GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Price-to-Owner-Earnings

Kee Song Bio-Technology Holdings (ROCO:1258) Price-to-Owner-Earnings : (As of Jun. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Price-to-Owner-Earnings?

As of today (2024-06-21), Kee Song Bio-Technology Holdings's share price is NT$26.85. Kee Song Bio-Technology Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings or its related term are showing as below:


ROCO:1258's Price-to-Owner-Earnings is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 15.02
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-21), Kee Song Bio-Technology Holdings's share price is NT$26.85. Kee Song Bio-Technology Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was NT$3.52. Therefore, Kee Song Bio-Technology Holdings's PE Ratio for today is 7.63.

As of today (2024-06-21), Kee Song Bio-Technology Holdings's share price is NT$26.85. Kee Song Bio-Technology Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was NT$3.52. Therefore, Kee Song Bio-Technology Holdings's PE Ratio without NRI for today is 7.63.


Kee Song Bio-Technology Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Price-to-Owner-Earnings Chart

Kee Song Bio-Technology Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 17.71

Kee Song Bio-Technology Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.85 10.86 - 17.71 7.79

Competitive Comparison of Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings

For the Packaged Foods subindustry, Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings falls into.



Kee Song Bio-Technology Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=26.85/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kee Song Bio-Technology Holdings  (ROCO:1258) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Kee Song Bio-Technology Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Traded in Other Exchanges
N/A
Address
Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104
Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines